CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 214 filers reported holding CYTOKINETICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,031 | -13.2% | 204,733 | -3.8% | 0.06% | +3.6% |
| Q2 2023 | $6,945 | -27.0% | 212,892 | -21.3% | 0.06% | -29.1% |
| Q1 2023 | $9,517 | +28.7% | 270,449 | +67.6% | 0.08% | -26.2% |
| Q4 2022 | $7,392 | -99.8% | 161,333 | +63.4% | 0.11% | +122.9% |
| Q2 2022 | $3,879,000 | +227.1% | 98,740 | +279.6% | 0.05% | +300.0% |
| Q4 2021 | $1,186,000 | -56.7% | 26,013 | -66.0% | 0.01% | -67.6% |
| Q3 2021 | $2,737,000 | +338.6% | 76,585 | +143.0% | 0.04% | +428.6% |
| Q2 2021 | $624,000 | -49.8% | 31,515 | -41.1% | 0.01% | -61.1% |
| Q1 2021 | $1,244,000 | +503.9% | 53,486 | +175.9% | 0.02% | +350.0% |
| Q4 2019 | $206,000 | – | 19,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |